
CAS 2169916-18-9
:Fórmula:C32H47FN6O4S
InChI:InChI=1S/C32H47FN6O4S/c1-22(2)39(23(3)4)31(40)27-16-25(33)8-11-28(27)43-29-17-34-21-35-30(29)38-19-32(20-38)12-14-37(15-13-32)18-24-6-9-26(10-7-24)36-44(5,41)42/h8,11,16-17,21-24,26,36H,6-7,9-10,12-15,18-20H2,1-5H3
Chave InChI:ADHHOUXZPBYYSU-UHFFFAOYSA-N
SMILES:CC(C)N(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)C
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 5 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
VTP50469
CAS:VTP50469 is a highly selective and orally active small molecule inhibitor of the Menin-MLL protein-protein interaction.Cost-effective and quality-assured.Fórmula:C32H47FN6O4SPureza:98.31% - 99.65%Cor e Forma:SolidPeso molecular:630.8175-Fluoro-N,N-diisopropyl-2-((4-(7-((trans-4-(methylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)benzamide
CAS:5-Fluoro-N,N-diisopropyl-2-((4-(7-((trans-4-(methylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)benzamideFórmula:C32H47FN6O4SPureza:98%Peso molecular:630.82VTP50469
CAS:VTP50469 is a synthetic analogue of the fatty acid cay10666, which has been shown to inhibit the proliferation of leukemia cells in vitro. VTP50469 is also effective against cancer cell lines derived from various organs, including carcinoma cell lines and epidermal growth factor-secreting cells. The mechanism of action of VTP50469 may be related to its ability to interact with DNA polymerase during DNA synthesis or replication, resulting in inhibition of the enzyme's activity. The effect of VTP50469 can be synergistic with other chemotherapeutic agents such as cisplatin, doxorubicin, and vincristine. This drug has also been shown to have anti-angiogenic properties and inhibit tumor growth in vivo.Fórmula:C32H47FN6O4SPureza:Min. 95%Peso molecular:630.8 g/mol




